MelliCell is a pioneering biotechnology company based in Newton, MA, dedicated to revolutionizing the treatment of diabetes and metabolic diseases. With a focus on understanding and addressing the root cause of diabetes at the cellular level, MelliCell develops innovative drug therapies that target fat cells to restore metabolic regulation and improve overall health.
Driven by a team of passionate scientists and entrepreneurs, MelliCell utilizes cutting-edge stem-cell technology to replicate human cells with unparalleled accuracy, accelerating the development of drugs that promote weight loss and aim to ultimately find a cure for diabetes. Recognized by leaders in the pharmaceutical and biotechnology sectors, MelliCell is at the forefront of industry standards, leading the way in innovative approaches to combatting diabetes.
Generated from the website